Congressman Ed Markey Seal
Spacer
Dark Fade Image
Dotted Div
Email Me
Dark Fade Image
Markey Media
Bottom Fade
House Speaker Pelosi
Majority Leader Hoyer
House Democratic Whip
House Democrats
Subscribe to RSS Feeds
Dark Fade Top
Medford
5 High Street, Suite 101
Medford, MA 02155
781-396-2900
Dark Div
Framingham
188 Concord Street
Suite 102
Framingham, MA 01702
508-875-2900
TTY Line: 508-820-1802
Dark Div
Washington, D.C.
2108 Rayburn House
Office Building
Washington, D.C. 20515
202-225-2836
Spacer
Spacer
FDA Oversight & Reform
Introduction | Press Releases | Legislation | Documents & Videos
Rep. Markey has long been in favor of sweeping FDA overhaul, aimed at restoring the public’s faith in the drug approval system. In a FDA reform bill singed into law in 2007, Rep. Markey negotiated provisions to give the FDA the authority to require label changes, order post-market studies to follow up on safety concerns and gather information needed to reassess the risks compared to the benefits of a drug already on the market, as well as establish an online clinical trials registry and a clinical trials results database, both available to the public.

Press Releases

Oct. 28, 2008 - Will FDA Follow BPA Scientists’ Recommendations or Yield to Industry Pressure?

Oct. 23, 2008 - Canadian BPA Ban Should Boost Similar Efforts in U.S.

Oct. 14, 2008 - Markey: $5 Million Gift Creates Potential Conflict of Interest on FDA Panel

June 10, 2008 - BPA Risk Too High, Markey Proposes 100% Ban in Food, Drink Containers

SEPT. 28, 2007 - MARKEY URGES STRONGER PATIENT PROTECTIONS DURING DRUG RESEARCH TRIALS

View All Related Press Releases >

Legislation

Feb. 16, 2007 - H.R.1165 - The SAFE Drug Act - To amend the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs, to establish whistleblower protections for certain individuals, and for other purposes.

Documents & Videos

October 23, 2008 - LETTER - Markey Presses FDA to Follow Canadian Ban on BPA

October 14, 2008 - LETTER - Markey Calls on FDA to Review Potential Conflict of Interest Related to BPA Safety Review

July 11, 2007 - VIDEO - WITH MARKEY'S HELP DRUG STUDIES, RESULTS WILL BE AVAILABLE TO ALL



Spacer Spacer
Bill Search
Search the Library of Congress THOMAS system for legislation
Spacer
Spacer
Home   |   About Ed   |   News   |   Services   |   Issues   |   7th District   |   Contact Ed   |   Privacy & Security Policy
Footer Left Footer Right
Get Rss Podcasting Feed Get Rss News Feed
Spacer
Office of Congressman Markey | 2108 Rayburn House Office Building, Washington DC 20515 | p: 202-225-2836
Spacer